Appendix 4D - Half Year Accounts - 31 December 2020
Filed with ASX · · 23 pages · English
1. Company details Name of entity: Patrys Limited Previous period: For the half-year ended 31 December 2019 2. Results for announcement to the market $ Revenues from ordinary activities up 78.1% to 214,623 Loss from ordinary activities after tax attributable to the Owners of Patrys Limited up 17.2% to (2,004,257) Loss for the half-year attributable to the Owners of Patrys Limited up 17.2% to (2,00
Story so far
Earlier from Patrys
- Patrys Successfully Establishes PAT-DX1 Stable Cell Line
- Appendix 4C - Quarterly - 31 December 2020
- $7.3M Capital Raising
- Investor Presentation - November 2020 - Updated
- Investor Presentation - November 2020
Later from Patrys
- New United States patent granted for Patrys deoxymab assets
- Appendix 4C - Quarterly - 31 March 2021
- Patrys receives R&D Tax Incentive refund
- Paper highlights PAT-DX1 as potential brain cancer treatment
- Patrys Limited Announces Publication of PAT-DX1 Preclinical Data in JCI - Insight
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys